Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 18 - Number 8


Review Article

The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies

, 18(8): 720 - 736

Avineesh Singh, Preeti Patel, Jageshwar, Vijay Kumar Patel, Deepak Kumar Jain, M. Kamal and Harish Rajak*


DOI: 10.2174/1568009617666170630124643



Review Article

Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents

, 18(8): 737 - 748

Leila Farahmand, Parnaz Merikhian, Neda Jalili, Behrad Darvishi and Keivan Majidzadeh-A*


DOI: 10.2174/1568009617666170623113520



Review Article

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

, 18(8): 749 - 772

Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra


DOI: 10.2174/1568009617666170623111953



Review Article

Therapeutic Approaches for the Treatment of Epidermal Growth Factor Receptor Mutated Lung Cancer

, 18(8): 773 - 791

Dhaval Sanchala, Lokesh K. Bhatt* and Kedar S. Prabhavalkar


DOI: 10.2174/1568009617666170623123848



Review Article

Development of Drug Targeting and Delivery in Cervical Cancer

, 18(8): 792 - 806

Urvashi Aggarwal, Amit Kumar Goyal and Goutam Rath*


DOI: 10.2174/1568009617666171009165105



Research Article

A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent

, 18(8): 807 - 815

Rand R. Hafidh*, Saba Z. Hussein, Mohammed Q. MalAllah, Ahmed S. Abdulamir and Fatimah Abu Bakar


DOI: 10.2174/1568009617666171114144236



Research Article

JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells

, 18(8): 816 - 828

Ilaria Zanellato*, Donato Colangelo and Domenico Osella


DOI: 10.2174/1568009617666170623101722




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog